ADMA Biologics Inc (ADMA)

ADMA Biologics Inc (ADMA $14.32)
- $14.32 P/E (TTM): 25.03X Cap: $3.84B
- View ADMA Profile
- View Questions on ADMA

{tplLang.businessdescription | toLang tLang}

{ profileData.description }

{tplLang.details | toLang tLang}

{tplLang.ceo | toLang tLang}

{profileData.profile.details.ceo}

{tplLang.employees | toLang tLang}

{profileData.profile.details.employees | numeraljs '0,0'}

{tplLang.issuetype | toLang tLang}

{profileData.profile.details.issuetype | asIssueType}

{tplLang.industryclassifications | toLang tLang}

{tplLang.sector | toLang tLang}

{profileData.profile.classification.sector}

{tplLang.industry | toLang tLang}

{profileData.profile.classification.industry}

{tplLang.toolname| toLang tLang}

There is no {tplLang.toolname| toLang tLang} currently available for {data.symbolstring}.

uniQure N.V. (QURE $16.09)
- $16.09 Cap: $996M
- View QURE Profile
- View Questions on QURE
Doximity Inc. Class A (DOCS $24.41)
- $24.41 P/E (TTM): 20.67X Cap: $4.50B
- View DOCS Profile
- View Questions on DOCS
ADMA Biologics Inc (ADMA $14.32)
- $14.32 P/E (TTM): 25.03X Cap: $3.84B
- View ADMA Profile
- View Questions on ADMA
National HealthCare Corporation (NHC $158.81)
- $158.81 P/E (TTM): 20.56X Cap: $2.50B
- View NHC Profile
- View Questions on NHC
Corvus Pharmaceuticals Inc. (CRVS $13.33)
- $13.33 Cap: $1.28B
- View CRVS Profile
- View Questions on CRVS

Q: Hi team,

In attempting to increase the health sector and possibly the international percentage of my portfolio, I am considering the following stocks: ADMA,NHC, QURE,DOCS, CRVS.

Would you recommend any of these or any others for a growth portfolio at this time ?

Gratefully,

Jacques IDS

Read Answer Asked by Jacques on March 16, 2026

ADMA Biologics Inc (ADMA $14.32)
- $14.32 P/E (TTM): 25.03X Cap: $3.84B
- View ADMA Profile
- View Questions on ADMA

Q: Hi !

Do you see potential for strong growth on the short term in any of the following names in the health sector : Adma Biologics (adma-q), Immunome (imnm-q), Janux Therapeutics (Janx-q), New Amsterdam Pharma (nams-q), National Healthcare (nhc-n), Summit Therapeutics (smmt-q), Oncology Institute (toi-q), Verona Pharma (vrna-q), Verastem (vstm-q) ?

Please deduct credits as you see fit.

Gratefully,

Jacques IDS

Read Answer Asked by Jacques on August 22, 2025